companydata.dkcompanydata.dk

FERTIN PHARMA A/S: Financial statements 2025

CVR: 25834844

Source: annual report 2025, Danish Business Authority

01/01/2025 – 31/12/2025

FERTIN PHARMA A/S (CVR 25834844) has filed annual accounts for 2025. In 2025, the company reported revenue of DKK 1,344,394,000 and a net result of DKK -280,841,000 compared with DKK -259,011,000 the year before. That is an increase of 21.8% compared with the year before. The profit margin was -20.9%. Equity in the 2025 report amounted to DKK 1,269,900,000. The solvency ratio was 37%. The company had 1,067 employees in the financial year.

Revenue
DKK 1,344,394,000
Gross Profit
DKK 716,658,000
Profit/Loss
DKK -280,841,000
Equity
DKK 1,269,900,000
Total Assets
DKK 3,433,312,000
Employees
1,067

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
20251.3B716.7M-280.8M1.3B1067
20241.1B99.9M-259M1.5B690
20231B34.1M-136.7M458.4M654
2022892.6M25.2M-91.4M596.3M622
2021932.5M161.4M37.6M681.4M569

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is FERTIN PHARMA A/S?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2025

FERTIN PHARMA A/S: The 2024 annual report is outJun 19, 2025

FERTIN PHARMA A/S has published its annual report for 2024. Revenue came to DKK 1,104,175,000, and the net result was DKK -259,011,000.

About FERTIN PHARMA A/S

FERTIN PHARMA A/S is a Danish company of the type Aktieselskab based in Vejle, founded in 2001. The company is registered under the industry Fremstilling af andre fødevarer i.a.n.. The company was previously named JUT NR. 2128 A/S. The management consists of Michael Henrik Thomsen. The board consists of Christopher Beck Lambert (chair), Bo Korsgaard Jensen, Jovana Mejri and Michael Henrik Thomsen. The company is owned by Aspeya Inc.. The company has 959 employees (2026). In 2025, the company reported revenue of DKK 1,344,394,000 and a net result of DKK -280,841,000 compared with DKK -259,011,000 the year before. Equity in the 2025 report amounted to DKK 1,269,900,000.

Source: annual report 2025, Danish Business Authority